<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03042234</url>
  </required_header>
  <id_info>
    <org_study_id>japarecido</org_study_id>
    <secondary_id>34634414.5.0000.5479</secondary_id>
    <secondary_id>1.227.250</secondary_id>
    <nct_id>NCT03042234</nct_id>
  </id_info>
  <brief_title>Influence of High-intensity Interval Training in Obese Adolescents With and Without Insulin Resistance ()</brief_title>
  <official_title>Influence of High-intensity Interval Training on the Anaerobic Threshold and Substrates Oxidation in Obese Adolescents With and Without Insulin Resistance</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Faculdade de Ciências Médicas da Santa Casa de São Paulo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Faculdade de Ciências Médicas da Santa Casa de São Paulo</source>
  <brief_summary>
    <textblock>
      According to the literature, high-intensity interval training (HIIT) emerges as a potential
      training strategy capable of promoting positive adaptations to the health of obese children
      and adolescents, as it demands less execution time (less volume) and can be considered
      motivationally, More attractive to this audience. However, few studies have adopted the
      &quot;anaerobic threshold&quot; concept and high intensity interval cardiorespiratory training to
      evaluate the oxidation of energetic substrates during and after physical activity in obese
      adolescents with and without insulin resistance.

      In this context, this study aims to analyze the effects of high intensity interval training
      on lipid and glycemic profile, cardiorespiratory parameters, metabolism of substrates, and
      functional capacity of obese adolescents with and without insulin resistance.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">February 2, 2017</start_date>
  <completion_date type="Anticipated">February 2, 2018</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Respiratory exchange ratio measured by ergospirometry at rest</measure>
    <time_frame>Baseline and 4 weeks (end of intervention)</time_frame>
    <description>Assessed using a maximal treadmill test.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Peak VO2 measured by ergospirometry during maximal exercise testing</measure>
    <time_frame>Baseline and 4 weeks (end of intervention)</time_frame>
    <description>Assessed using a maximal treadmill test.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Ventilatory threshold measured by ergospirometry during maximal exercise testing</measure>
    <time_frame>Baseline and 4 weeks (end of intervention)</time_frame>
    <description>Assessed using a maximal treadmill test.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>FATmax (% of maximal oxygen consumption)</measure>
    <time_frame>Baseline and 4 weeks (end of intervention)</time_frame>
    <description>Assessed during the incremental stage maximal cardio-respiratory fitness test</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Whole-body substrate oxidation rates</measure>
    <time_frame>Baseline and 4 weeks (end of intervention)</time_frame>
    <description>Assessed during the incremental stage maximal cardio-respiratory fitness test</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Body Weight</measure>
    <time_frame>Baseline and 4 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood Pressure</measure>
    <time_frame>Baseline and 4 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body Mass Index</measure>
    <time_frame>Baseline and 4 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body composition</measure>
    <time_frame>Baseline and 4 weeks</time_frame>
    <description>Assessed using Bioelectric impedance (using Biodynamics 450)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood biochemistry</measure>
    <time_frame>Baseline and 4 weeks</time_frame>
    <description>Analysed for lipids</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood biochemistry</measure>
    <time_frame>Baseline and 4 weeks</time_frame>
    <description>Analysed for glucose</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood biochemistry</measure>
    <time_frame>Baseline and 4 weeks</time_frame>
    <description>Analysed for insulin</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood biochemistry</measure>
    <time_frame>Baseline and 4 weeks</time_frame>
    <description>Analysed for HOMA-index by measuring the blood glucose and fasting insulin.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physical activity</measure>
    <time_frame>Baseline and 4 weeks</time_frame>
    <description>Assessed through IPAQ</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>Baseline and 4 weeks</time_frame>
    <description>Assessed through the Paediatric Quality of Life Inventory</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maximum respiratory pressure measurements by means of a manometer: maximum inspiratory pressure (Pimax)</measure>
    <time_frame>Baseline and 4 weeks</time_frame>
    <description>Assessed using a manovacuometer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maximum respiratory pressure measurements by means of a manometer: maximum expiratory pressure (Pemax)</measure>
    <time_frame>Baseline and 4 weeks</time_frame>
    <description>Assessed using a manovacuometer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Spirometric analysis</measure>
    <time_frame>change from baseline at 4 weeks</time_frame>
    <description>Analysed for forced vital capacity. Assessed using a Software Koko Spirometer, Spirometer Koko (PDS Instrumentation®).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Spirometric analysis</measure>
    <time_frame>change from baseline at 4 weeks</time_frame>
    <description>Analysed for forced expiratory volume in the first second. Assessed using a Software Koko Spirometer, Spirometer Koko (PDS Instrumentation®).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Spirometric analysis</measure>
    <time_frame>change from baseline at 4 weeks</time_frame>
    <description>Analysed for forced expiratory flow 25-75 %. Assessed using a Software Koko Spirometer, Spirometer Koko (PDS Instrumentation®).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Spirometric analysis</measure>
    <time_frame>change from baseline at 4 weeks</time_frame>
    <description>Analysed for ratio of forced expiratory volume in the first second. Assessed using a Software Koko Spirometer, Spirometer Koko (PDS Instrumentation®).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Six-minute walk test</measure>
    <time_frame>change from baseline at 4 weeks</time_frame>
    <description>Analysis of distance in six-minute walk test.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Six-minute walk test</measure>
    <time_frame>change from baseline at 4 weeks</time_frame>
    <description>Analysis of oxygen saturation at end of test.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Six-minute walk test</measure>
    <time_frame>change from baseline at 4 weeks</time_frame>
    <description>Analysis of blood pressure at end of test.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Six-minute walk test</measure>
    <time_frame>change from baseline at 4 weeks</time_frame>
    <description>Analysis of heart rate at end of test.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Six-minute step test</measure>
    <time_frame>change from baseline at 4 weeks</time_frame>
    <description>Analysis of distance in six-minute step test.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Six-minute step test</measure>
    <time_frame>change from baseline at 4 weeks</time_frame>
    <description>Analysis of oxygen saturation at end of test.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Six-minute step test</measure>
    <time_frame>change from baseline at 4 weeks</time_frame>
    <description>Analysis of blood pressure at end of test.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Six-minute step test</measure>
    <time_frame>change from baseline at 4 weeks</time_frame>
    <description>Analysis of heart rate at end of test.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Obesity</condition>
  <condition>Insulin Resistance</condition>
  <condition>Adolescent</condition>
  <arm_group>
    <arm_group_label>Group I</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Adolescents obese with insulin resistance</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group II</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Adolescents obese without insulin resistance</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group III</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Adolescents eutrophyc</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Group I</intervention_name>
    <description>High intensity interval training: 3 to 6 sets of 60-second sprints at 100% of the peak velocity interspersed by a 3-min active recovery period.</description>
    <arm_group_label>Group I</arm_group_label>
    <other_name>Adolescents obese with insulin resistance</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Group II</intervention_name>
    <description>High intensity interval training: 3 to 6 sets of 60-second sprints at 100% of the peak velocity interspersed by a 3-min active recovery period.</description>
    <arm_group_label>Group II</arm_group_label>
    <other_name>Adolescent obese without insulin resistance</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Group III</intervention_name>
    <description>High intensity interval training: 3 to 6 sets of 60-second sprints at 100% of the peak velocity interspersed by a 3-min active recovery period.</description>
    <arm_group_label>Group III</arm_group_label>
    <other_name>Adolescent eutrophyc</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age between 8 and 12 years;

          -  Pubertal stage &gt;3, acooording to the Tanner system of pubertal staging;

          -  Sedentary or irregurarly active, according to theIPAQ;

          -  Body mass index (BMI), according to the World Health Organization;

          -  No pharmacological treatment;

          -  No evidence of metabolic, hormonal, orthopedic, and cardiovascular disease at the time
             of the study's commencement;

          -  No participation in any regular exercise training program (except physical education
             classes, two days a week) at least 6 months before the commencement of the study and
             throughout the protocol.

        Exclusion Criteria:

        • Participants with cardiovascular diseases or any other condition that could preclude the
        participation in the the exercise training program
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>16 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Juliana Monique Lino Aparecido</last_name>
    <role>Principal Investigator</role>
    <affiliation>Faculdade de Ciências Médicas da Santa Casa de São Paulo</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Juliana Monique Lino Aparecido</last_name>
    <phone>+55-11-969975162</phone>
    <email>juliana.monique@unicid.edu.br</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Vera Lúcia dos Santos Alves, PhD</last_name>
    <phone>+55-11-999707013</phone>
    <email>fisioterapiasc@uol.com.br</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Santa Casa of Sao Paulo School</name>
      <address>
        <city>Sao Paulo</city>
        <zip>01221-020</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <reference>
    <citation>ROSSETTI, MB; BRITO, RR; NORTON, RC. Prevenção primária de doenças cardiovasculares na obesidade infatojuvenil: efeito anti-inflamatório do exercício físico. Rev Bras Med Esporte. 2009</citation>
  </reference>
  <reference>
    <citation>Corte de Araujo AC, Roschel H, Picanço AR, do Prado DM, Villares SM, de Sá Pinto AL, Gualano B. Similar health benefits of endurance and high-intensity interval training in obese children. PLoS One. 2012;7(8):e42747. doi: 10.1371/journal.pone.0042747. Epub 2012 Aug 6.</citation>
    <PMID>22880097</PMID>
  </reference>
  <reference>
    <citation>KLOSTER, R &amp; LIBERALI, R. Emagrecimento: composição da dieta e exercício físico. Rev Bras Nutr Esportiva. 2012 set-out; 11(2):288-306</citation>
  </reference>
  <reference>
    <citation>FOUREAUX, G; PINTO, KMC; DÂMASO, A. Efeito do consumo excessivo de oxigênio após exercício e da taxa metabólica de repouso no gasto energético. Rev Bras Med Esporte. 2006 nov-dez; 12(6):393-398.</citation>
  </reference>
  <reference>
    <citation>AMERICAN COLLEGE OF SPORTS MEDICINE - ACSM. ACSM's Guidelines for Exercise Testing and Prescription. 8ª edição. Baltimore: Williams &amp; Wilkins, 2009.</citation>
  </reference>
  <reference>
    <citation>Aucouturier J, Rance M, Meyer M, Isacco L, Thivel D, Fellmann N, Duclos M, Duché P. Determination of the maximal fat oxidation point in obese children and adolescents: validity of methods to assess maximal aerobic power. Eur J Appl Physiol. 2009 Jan;105(2):325-31. doi: 10.1007/s00421-008-0907-3. Epub 2008 Nov 12.</citation>
    <PMID>19002708</PMID>
  </reference>
  <reference>
    <citation>MARQUEZI, ML. Adaptações decorrentes do exercício cardiorrespiratório sobre a oxidação de lipídeos: exercício aeróbio. Rev Mackenzie de Educação Física e Esporte. 2010; 9(1):32-35.</citation>
  </reference>
  <reference>
    <citation>Achten J, Gleeson M, Jeukendrup AE. Determination of the exercise intensity that elicits maximal fat oxidation. Med Sci Sports Exerc. 2002 Jan;34(1):92-7.</citation>
    <PMID>11782653</PMID>
  </reference>
  <reference>
    <citation>Achten J, Jeukendrup AE. Relation between plasma lactate concentration and fat oxidation rates over a wide range of exercise intensities. Int J Sports Med. 2004 Jan;25(1):32-7.</citation>
    <PMID>14750010</PMID>
  </reference>
  <reference>
    <citation>MARQUEZI, ML; DUARTE, L; SCHWARTZ, J; SOUSA, PCR. Variabilidade interindividual da oxidação de substratos durante o exercício. Rev Mackenzie de Educação Física e Esporte. 2009; 8(1): 3-19.</citation>
  </reference>
  <reference>
    <citation>Carey DG. Quantifying differences in the &quot;fat burning&quot; zone and the aerobic zone: implications for training. J Strength Cond Res. 2009 Oct;23(7):2090-5. doi: 10.1519/JSC.0b013e3181bac5c5.</citation>
    <PMID>19855335</PMID>
  </reference>
  <reference>
    <citation>Braun B, Sharoff C, Chipkin SR, Beaudoin F. Effects of insulin resistance on substrate utilization during exercise in overweight women. J Appl Physiol (1985). 2004 Sep;97(3):991-7. Epub 2004 May 7.</citation>
    <PMID>15133003</PMID>
  </reference>
  <reference>
    <citation>Blaak EE, van Aggel-Leijssen DP, Wagenmakers AJ, Saris WH, van Baak MA. Impaired oxidation of plasma-derived fatty acids in type 2 diabetic subjects during moderate-intensity exercise. Diabetes. 2000 Dec;49(12):2102-7.</citation>
    <PMID>11118013</PMID>
  </reference>
  <reference>
    <citation>Borghouts LB, Wagenmakers AJ, Goyens PL, Keizer HA. Substrate utilization in non-obese Type II diabetic patients at rest and during exercise. Clin Sci (Lond). 2002 Dec;103(6):559-66.</citation>
    <PMID>12444908</PMID>
  </reference>
  <reference>
    <citation>Pérez-Martin A, Dumortier M, Raynaud E, Brun JF, Fédou C, Bringer J, Mercier J. Balance of substrate oxidation during submaximal exercise in lean and obese people. Diabetes Metab. 2001 Sep;27(4 Pt 1):466-74.</citation>
    <PMID>11547220</PMID>
  </reference>
  <reference>
    <citation>Gibala MJ, Little JP, Macdonald MJ, Hawley JA. Physiological adaptations to low-volume, high-intensity interval training in health and disease. J Physiol. 2012 Mar 1;590(5):1077-84. doi: 10.1113/jphysiol.2011.224725. Epub 2012 Jan 30. Review.</citation>
    <PMID>22289907</PMID>
  </reference>
  <reference>
    <citation>Donnelly JE, Blair SN, Jakicic JM, Manore MM, Rankin JW, Smith BK; American College of Sports Medicine. American College of Sports Medicine Position Stand. Appropriate physical activity intervention strategies for weight loss and prevention of weight regain for adults. Med Sci Sports Exerc. 2009 Feb;41(2):459-71. doi: 10.1249/MSS.0b013e3181949333. Erratum in: Med Sci Sports Exerc. 2009 Jul;41(7):1532.</citation>
    <PMID>19127177</PMID>
  </reference>
  <reference>
    <citation>Burgomaster KA, Howarth KR, Phillips SM, Rakobowchuk M, Macdonald MJ, McGee SL, Gibala MJ. Similar metabolic adaptations during exercise after low volume sprint interval and traditional endurance training in humans. J Physiol. 2008 Jan 1;586(1):151-60. Epub 2007 Nov 8.</citation>
    <PMID>17991697</PMID>
  </reference>
  <reference>
    <citation>Talanian JL, Holloway GP, Snook LA, Heigenhauser GJ, Bonen A, Spriet LL. Exercise training increases sarcolemmal and mitochondrial fatty acid transport proteins in human skeletal muscle. Am J Physiol Endocrinol Metab. 2010 Aug;299(2):E180-8. doi: 10.1152/ajpendo.00073.2010. Epub 2010 May 18.</citation>
    <PMID>20484014</PMID>
  </reference>
  <reference>
    <citation>Tjønna AE, Lee SJ, Rognmo Ø, Stølen TO, Bye A, Haram PM, Loennechen JP, Al-Share QY, Skogvoll E, Slørdahl SA, Kemi OJ, Najjar SM, Wisløff U. Aerobic interval training versus continuous moderate exercise as a treatment for the metabolic syndrome: a pilot study. Circulation. 2008 Jul 22;118(4):346-54. doi: 10.1161/CIRCULATIONAHA.108.772822. Epub 2008 Jul 7.</citation>
    <PMID>18606913</PMID>
  </reference>
  <reference>
    <citation>Talanian JL, Galloway SD, Heigenhauser GJ, Bonen A, Spriet LL. Two weeks of high-intensity aerobic interval training increases the capacity for fat oxidation during exercise in women. J Appl Physiol (1985). 2007 Apr;102(4):1439-47. Epub 2006 Dec 14.</citation>
    <PMID>17170203</PMID>
  </reference>
  <reference>
    <citation>Perry CG, Heigenhauser GJ, Bonen A, Spriet LL. High-intensity aerobic interval training increases fat and carbohydrate metabolic capacities in human skeletal muscle. Appl Physiol Nutr Metab. 2008 Dec;33(6):1112-23. doi: 10.1139/H08-097.</citation>
    <PMID>19088769</PMID>
  </reference>
  <reference>
    <citation>Little JP, Safdar A, Wilkin GP, Tarnopolsky MA, Gibala MJ. A practical model of low-volume high-intensity interval training induces mitochondrial biogenesis in human skeletal muscle: potential mechanisms. J Physiol. 2010 Mar 15;588(Pt 6):1011-22. doi: 10.1113/jphysiol.2009.181743. Epub 2010 Jan 25.</citation>
    <PMID>20100740</PMID>
  </reference>
  <reference>
    <citation>Little JP, Safdar A, Bishop D, Tarnopolsky MA, Gibala MJ. An acute bout of high-intensity interval training increases the nuclear abundance of PGC-1α and activates mitochondrial biogenesis in human skeletal muscle. Am J Physiol Regul Integr Comp Physiol. 2011 Jun;300(6):R1303-10. doi: 10.1152/ajpregu.00538.2010. Epub 2011 Mar 30.</citation>
    <PMID>21451146</PMID>
  </reference>
  <reference>
    <citation>Baquet G, Gamelin FX, Mucci P, Thévenet D, Van Praagh E, Berthoin S. Continuous vs. interval aerobic training in 8- to 11-year-old children. J Strength Cond Res. 2010 May;24(5):1381-8. doi: 10.1519/JSC.0b013e3181d1575a.</citation>
    <PMID>20440122</PMID>
  </reference>
  <reference>
    <citation>de Onis M, Onyango AW, Borghi E, Siyam A, Nishida C, Siekmann J. Development of a WHO growth reference for school-aged children and adolescents. Bull World Health Organ. 2007 Sep;85(9):660-7.</citation>
    <PMID>18026621</PMID>
  </reference>
  <reference>
    <citation>TANNER JM. Growth at adolescence. Oxford: Blackwell Scientific Pub; 1962.</citation>
  </reference>
  <reference>
    <citation>MATSUDO, SM; ARAÚJO, TL; MATSUDO, VKR; ANDRADE, DR; ANDRADE, EL; OLIVEIRA, LC; et al. Questionário Internacional de Atividade Física (IPAQ): estudo de validade e reprodutibilidade no Brasil. Rev Bras Ativ Saude. 2001;10:5-18.</citation>
  </reference>
  <reference>
    <citation>Pereira CA, Sato T, Rodrigues SC. New reference values for forced spirometry in white adults in Brazil. J Bras Pneumol. 2007 Jul-Aug;33(4):397-406. English, Portuguese.</citation>
    <PMID>17982531</PMID>
  </reference>
  <reference>
    <citation>Caiozzo VJ, Davis JA, Ellis JF, Azus JL, Vandagriff R, Prietto CA, McMaster WC. A comparison of gas exchange indices used to detect the anaerobic threshold. J Appl Physiol Respir Environ Exerc Physiol. 1982 Nov;53(5):1184-9.</citation>
    <PMID>7174412</PMID>
  </reference>
  <reference>
    <citation>WASSERMAN K, MCILROY MB. DETECTING THE THRESHOLD OF ANAEROBIC METABOLISM IN CARDIAC PATIENTS DURING EXERCISE. Am J Cardiol. 1964 Dec;14:844-52.</citation>
    <PMID>14232808</PMID>
  </reference>
  <reference>
    <citation>Bhambhani Y, Singh M. Ventilatory thresholds during a graded exercise test. Respiration. 1985;47(2):120-8.</citation>
    <PMID>4001567</PMID>
  </reference>
  <reference>
    <citation>Gmada N, Marzouki H, Haboubi M, Tabka Z, Shephard RJ, Bouhlel E. Crossover and maximal fat-oxidation points in sedentary healthy subjects: methodological issues. Diabetes Metab. 2012 Feb;38(1):40-5. doi: 10.1016/j.diabet.2011.07.004. Epub 2011 Sep 25.</citation>
    <PMID>21944864</PMID>
  </reference>
  <reference>
    <citation>Chenevière X, Malatesta D, Peters EM, Borrani F. A mathematical model to describe fat oxidation kinetics during graded exercise. Med Sci Sports Exerc. 2009 Aug;41(8):1615-25. doi: 10.1249/MSS.0b013e31819e2f91.</citation>
    <PMID>19568198</PMID>
  </reference>
  <reference>
    <citation>Lanzi S, Codecasa F, Cornacchia M, Maestrini S, Salvadori A, Brunani A, Malatesta D. Fat oxidation, hormonal and plasma metabolite kinetics during a submaximal incremental test in lean and obese adults. PLoS One. 2014 Feb 11;9(2):e88707. doi: 10.1371/journal.pone.0088707. eCollection 2014.</citation>
    <PMID>24523934</PMID>
  </reference>
  <verification_date>February 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 30, 2017</study_first_submitted>
  <study_first_submitted_qc>February 1, 2017</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 3, 2017</study_first_posted>
  <last_update_submitted>February 1, 2017</last_update_submitted>
  <last_update_submitted_qc>February 1, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 3, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Faculdade de Ciências Médicas da Santa Casa de São Paulo</investigator_affiliation>
    <investigator_full_name>JULIANA MONIQUE LINO</investigator_full_name>
    <investigator_title>Principal investigator Juliana Monique Lino Aparecido</investigator_title>
  </responsible_party>
  <keyword>Obesity</keyword>
  <keyword>Exercise</keyword>
  <keyword>Fat oxidation</keyword>
  <keyword>Adolescent</keyword>
  <keyword>Insulin resistance</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin Resistance</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin, Globin Zinc</mesh_term>
    <mesh_term>Insulin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

